While the main neuropathological hallmarks characterizing AD, such as extracellular amyloid deposition, micro- and astrogliosis, as well as learning and memory deficits, have been successfully modelled in transgenic mice relying on APP overexpression, robust neuron loss is much less evident [66,67]. The gene discussed is APP; the disease is Alzheimer disease.